Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice.
Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice.
复制标题
DOI:
10.1161/circulationaha.109.924886
复制
发表时间:
2010-04-20
期刊:
影响因子:
37.8
通讯作者:
Galkina E
中科院分区:
文献类型:
--
作者:
Smith E;Prasad KM;Butcher M;Dobrian A;Kolls JK;Ley K;Galkina E
T cells play an important role during the immune response that accompanies atherosclerosis. To date, the role for IL-17A in atherogenesis is not well-defined. Here, we tested the hypothesis that atherosclerosis-prone conditions induce the differentiation of IL-17A-producing T cells, which in turn promote atherosclerosis. IL-17A was found elevated in the plasma and tissues of apolipoprotein E-deficient (Apoe−/−) mice. IL-17A-expressing T cells were significantly increased in the aortas, spleen and lamina propria of aged Apoe−/− mice compared to age-matched C57BL/6 mice. IL-17A+ T cells resided in both, adventitia and aortas of aged Apoe−/− mice on chow diet. Elevated levels of IL-17A+ T cells were also detected in the aortas of 21 week old Apoe−/− mice fed western diet for 15 weeks. IL-17A+ T cells were characterized as predominantly CD4+ Th17 and γδ+ T cells. Blockade of IL-17A in Apoe−/− mice using adenovirus-produced IL-17RA reduced plaque burden in Apoe−/− mice fed western diet for 15 weeks. Also, the treatment diminished circulating IL-6 and G-CSF levels, and limited CXCL1 expression and macrophage content within the aortas. Conversely, IL-17A treatment of whole aorta isolated from Apoe−/− mice, using an ex vivo adhesion assay, promoted monocyte adhesion and CXCL1 expression. - These results demonstrate that atherosclerosis-prone conditions induce the differentiation of IL-17A-producing T cells. IL-17A plays a pro-atherogenic inflammatory role during atherogenesis by promoting monocyte/macrophage recruitment into the aortic wall.